Potential use of peptides mimicking CRAC/CARC domains as antivirulence therapies to inhibit RTX toxins activities
In recent years, research efforts have increased to develop new therapeutics aimed at combating antibiotic-resistant bacterial infections. These efforts focus on inhibiting the virulence factors bacteria secrete to proliferate. This review aims to highlight the advances in these antivirulence therap...
Saved in:
Main Author: | Vanesa Herlax |
---|---|
Format: | Article |
Language: | English |
Published: |
Open Exploration
2024-11-01
|
Series: | Exploration of Drug Science |
Subjects: | |
Online Access: | https://www.explorationpub.com/uploads/Article/A100876/100876.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prevalence of the oral pathogen Filifactor alocis and its FtxA toxin related to clinical parameters and presence of Aggregatibacter actinomycetemcomitans
by: Zeinab Razooqi, et al.
Published: (2025-01-01) -
A Phage‐Based Approach to Identify Antivirulence Inhibitors of Bacterial Type IV Pili
by: Tori M. Shimozono, et al.
Published: (2025-01-01) -
Investigation of potential Shiga toxin producing Escherichia coli (STEC) associated with a local foodborne outbreak using multidisciplinary approaches
by: Kristen A. Lozinak, et al.
Published: (2016-09-01) -
Genetic Characterization of Escherichia coli O157 Isolated From Human Stool Specimens in Wassit Province of Iraq
by: Sabah M. Jwied, et al.
Published: (2020-09-01) -
Characterization of Broad Spectrum Bacteriophage vB ESM-pEJ01 and Its Antimicrobial Efficacy Against Shiga Toxin-Producing <i>Escherichia coli</i> in Green Juice
by: Eun Jeong Park, et al.
Published: (2025-01-01)